Live Breaking News & Updates on Eha Congress

Stay updated with breaking news from Eha congress. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

IBI322 Shows Early Antitumor Efficacy in PD-1/PD-L1–Resistant Classical Hodgkin Lymphoma

Single-agent IBI322 elicited responses with favorable safety in patients with classical Hodgkin lymphoma that had become resistant to anti–PD-1/PD-L1 therapy, according to data from a phase 1 trial. ....

Jingwei Yu , Tianjin Medical University Cancer Institute Hospital , Tianjin Medical University Cancer Institute , Ann Arbor , Classical Hodgkin Lymphoma , Eha Congress ,

Dr Gill on the Efficacy and Genomic Features of Ropeginterferon Alfa-2B in Myelofibrosis

Harry Gill, MD, FRCP, FRCPath, discusses updated efficacy data and analysis of genomic characteristics for ropeginterferon alfa-2B in primary myelofibrosis. ....

Hong Kong , Harry Gill , Li Ka Shing , Dynamic International Prognostic Scoring System , Hong Kong University Of Medicine , Department Of Medicine , Hong Kong University , Dynamic International Prognostic Scoring , Eha Congress , Ct04988815 , Ropeginterferon Alfa 2b ,

Dr Mohty on Extended Follow-up Data from MagnetisMM-3 With Elranatamab in R/R Myeloma

Mohamad Mohty, MD, PhD, discusses extended follow-up from cohort A of the phase 2 MagnetisMM-3 trial of elranatamab in patients with relapsed/refractory multiple myeloma. ....

France General , Mohamad Mohty , International Staging System , Sorbonne University , Cellular Therapy Department At Saint Antoine Hospital , Cellular Therapy Department , Saint Antoine Hospital , Revised International Staging System , Multiple Myeloma , Magnetismm 3 , Eha Congress ,

Dr Jabbour on the Efficacy of Ponatinib in Newly Diagnosed Ph+ ALL

Elias Jabbour, MD, discusses efficacy data from the phase 3 PhALLCON trial of ponatinib plus reduced-intensity chemotherapy vs imatinib plus reduced-intensity chemotherapy in newly diagnosed patients with Philadelphia chromosome–positive acute lymphoblastic leukemia. ....

United States , Elias Jabbour , Division Of Cancer Medicine , Department Of Leukemia , University Of Texas Md Anderson Cancer Center , Cancer Medicine , Cancer Center , Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia , Eha Congress ,

Dr Gill on the Evaluation of Oral Arsenic Trioxide Plus ATRA/Ascorbic Acid in APL

Harry Gill, MD, FRCP, FRCPath, discusses the investigation of an all-oral combination of arsenic trioxide, all trans retinoic acid, and ascorbic acid in patients with newly diagnosed acute promyelocytic leukemia. ....

Hong Kong , Harry Gill , Li Ka Shing , Hong Kong University Of Medicine , World Health Organization Classification , Department Of Medicine , Hong Kong University , Health Organization , All Trans Retinoic Acid , Arsenic Trioxide , Ascorbic Acid , Acute Promyelocytic Leukemia , Eha Congress ,